https://stock.noler.com/us/stock/calliditas-therapeutics-ab https://stock.noler.com/us/stock/calliditas-therapeutics-ab/accruals-and-deferred-income-classified-as-current https://stock.noler.com/us/stock/calliditas-therapeutics-ab/acquisitiondate-fair-value-of-total-consideration-transferred https://stock.noler.com/us/stock/calliditas-therapeutics-ab/acquisitionrelated-costs-for-transaction-recognised-separately-from-acquisition-of-assets-and-assumption-of-liabilities-in-business-combination https://stock.noler.com/us/stock/calliditas-therapeutics-ab/acquisitions-through-business-combinations-intangible-assets-and-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/additional-paidin-capital https://stock.noler.com/us/stock/calliditas-therapeutics-ab/additional-provisions-other-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/additions-to-rightofuse-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjusted-weighted-average-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-decrease-increase-in-inventories https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-decrease-increase-in-trade-account-receivable https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-increase-decrease-in-other-current-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-reconcile-profit-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/adjustments-for-share-based-payments https://stock.noler.com/us/stock/calliditas-therapeutics-ab/administrative-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/allowance-account-for-credit-losses-of-financial-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/applicable-tax-rate https://stock.noler.com/us/stock/calliditas-therapeutics-ab/auditors-remuneration https://stock.noler.com/us/stock/calliditas-therapeutics-ab/average-effective-tax-rate https://stock.noler.com/us/stock/calliditas-therapeutics-ab/average-exercise-price-of-other-equity-instruments-outstanding-in-share-based-payment-arrangement-2019 https://stock.noler.com/us/stock/calliditas-therapeutics-ab/average-number-of-employees https://stock.noler.com/us/stock/calliditas-therapeutics-ab/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/calliditas-therapeutics-ab/basic-earnings-loss-per-share https://stock.noler.com/us/stock/calliditas-therapeutics-ab/borrowings-interest-rate https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-and-cash-equivalents https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-and-cash-equivalents-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-flows-from-used-in-investing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-flows-from-used-in-operations-before-changes-in-working-capital https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-on-hand https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cash-transferred https://stock.noler.com/us/stock/calliditas-therapeutics-ab/comprehensive-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/comprehensive-income-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/calliditas-therapeutics-ab/comprehensive-income-attributable-to-owners-of-parent https://stock.noler.com/us/stock/calliditas-therapeutics-ab/contingent-consideration-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cost-of-inventories-recognised-as-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cost-of-sales https://stock.noler.com/us/stock/calliditas-therapeutics-ab/cover-page-shares-outstanding https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-advances https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-contract-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-lease-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-liabilities-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-prepaid-expenses https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-tax-expense-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/current-tax-liabilities-current https://stock.noler.com/us/stock/calliditas-therapeutics-ab/decrease-through-writeoff-financial-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-income-classified-as-current https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-expense-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-expense-income-recognised-in-profit-or-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-liabilities-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/deferred-tax-liability-asset https://stock.noler.com/us/stock/calliditas-therapeutics-ab/depreciation-amortisation-and-impairment-loss-reversal-of-impairment-loss-recognised-in-profit-or-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/depreciation-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/depreciation-property-plant-and-equipment https://stock.noler.com/us/stock/calliditas-therapeutics-ab/depreciation-rightofuse-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/description-of-discount-rates-used-in-current-estimate-of-value-in-use https://stock.noler.com/us/stock/calliditas-therapeutics-ab/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/calliditas-therapeutics-ab/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/calliditas-therapeutics-ab/employee-benefits-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/equity https://stock.noler.com/us/stock/calliditas-therapeutics-ab/equity-and-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/equity-attributable-to-owners-of-parent https://stock.noler.com/us/stock/calliditas-therapeutics-ab/estimated-financial-effect-of-contingent-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-by-nature https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-from-equitysettled-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-from-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-relating-to-leases-of-lowvalue-assets-for-which-recognition-exemption-has-been-used https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-relating-to-shortterm-leases-for-which-recognition-exemption-has-been-used https://stock.noler.com/us/stock/calliditas-therapeutics-ab/expense-relating-to-variable-lease-payments-not-included-in-measurement-of-lease-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/finance-costs https://stock.noler.com/us/stock/calliditas-therapeutics-ab/finance-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/finance-income-cost https://stock.noler.com/us/stock/calliditas-therapeutics-ab/financial-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/financial-assets-pledged-as-collateral-for-liabilities-or-contingent-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/financial-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/finished-goods https://stock.noler.com/us/stock/calliditas-therapeutics-ab/gains-losses-on-disposals-of-noncurrent-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/gains-losses-on-disposals-of-property-plant-and-equipment https://stock.noler.com/us/stock/calliditas-therapeutics-ab/gains-losses-on-exchange-differences-on-translation-net-of-tax https://stock.noler.com/us/stock/calliditas-therapeutics-ab/gains-on-disposals-of-property-plant-and-equipment https://stock.noler.com/us/stock/calliditas-therapeutics-ab/goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/goodwill-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/gross-profit https://stock.noler.com/us/stock/calliditas-therapeutics-ab/identifiable-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/calliditas-therapeutics-ab/impairment-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/impairment-loss-recognised-in-profit-or-loss-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/impairment-loss-recognised-in-profit-or-loss-intangible-assets-and-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/income-tax-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/income-taxes-paid-refund-classified-as-operating-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-in-cash-and-cash-equivalents-before-effect-of-exchange-rate-changes https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-in-contingent-consideration-asset-liability https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-in-number-of-shares-outstanding https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-in-working-capital https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-acquisition-of-subsidiary https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-business-combinations-deferred-tax-liability-asset https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-changes-in-ownership-interests-in-subsidiaries-that-do-not-result-in-loss-of-control https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-effect-of-changes-in-foreign-exchange-rates-liabilities-arising-from-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-financing-cash-flows-liabilities-arising-from-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-net-exchange-differences-deferred-tax-liability-asset https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-net-exchange-differences-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-net-exchange-differences-intangible-assets-and-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-net-exchange-differences-other-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-net-exchange-differences-property-plant-and-equipment https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-time-value-of-money-adjustment-other-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-transactions-with-owners https://stock.noler.com/us/stock/calliditas-therapeutics-ab/increase-decrease-through-treasury-share-transactions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/intangible-assets-and-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/calliditas-therapeutics-ab/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/interest-expense-on-other-financial-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/interest-paid-classified-as-operating-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/interest-received-classified-as-operating-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/inventories https://stock.noler.com/us/stock/calliditas-therapeutics-ab/inventory-writedown-2011 https://stock.noler.com/us/stock/calliditas-therapeutics-ab/issue-of-equity https://stock.noler.com/us/stock/calliditas-therapeutics-ab/issued-capital https://stock.noler.com/us/stock/calliditas-therapeutics-ab/lease-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/liabilities-arising-from-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/liabilities-from-share-based-payment-transactions-2011 https://stock.noler.com/us/stock/calliditas-therapeutics-ab/longterm-borrowings https://stock.noler.com/us/stock/calliditas-therapeutics-ab/losses-on-change-in-fair-value-of-derivatives https://stock.noler.com/us/stock/calliditas-therapeutics-ab/maximum-exposure-to-credit-risk https://stock.noler.com/us/stock/calliditas-therapeutics-ab/miscellaneous-other-operating-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/net-deferred-tax-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/net-deferred-tax-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/net-foreign-exchange-gain https://stock.noler.com/us/stock/calliditas-therapeutics-ab/net-foreign-exchange-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncontrolling-interest-in-acquiree-recognised-at-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncontrolling-interests https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-assets-other-than-financial-instruments-deferred-tax-assets-postemployment-benefit-assets-and-rights-arising-under-insurance-contracts https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-assets-recognised-as-of-acquisition-date https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-financial-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-lease-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/noncurrent-provisions-for-employee-benefits https://stock.noler.com/us/stock/calliditas-therapeutics-ab/number-of-other-equity-instruments-outstanding-in-share-based-payment-arrangement https://stock.noler.com/us/stock/calliditas-therapeutics-ab/number-of-outstanding-share-options https://stock.noler.com/us/stock/calliditas-therapeutics-ab/number-of-shares-issued https://stock.noler.com/us/stock/calliditas-therapeutics-ab/number-of-shares-outstanding https://stock.noler.com/us/stock/calliditas-therapeutics-ab/number-of-shares-represented-by-one-depositary-receipt https://stock.noler.com/us/stock/calliditas-therapeutics-ab/oci-attributable-to-owners-of-parent https://stock.noler.com/us/stock/calliditas-therapeutics-ab/oci-net-of-tax-exchange-differences-on-translation https://stock.noler.com/us/stock/calliditas-therapeutics-ab/oci-net-of-tax-gains-losses-on-remeasurements-of-defined-benefit-plans https://stock.noler.com/us/stock/calliditas-therapeutics-ab/oci-that-will-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/calliditas-therapeutics-ab/oci-that-will-not-be-reclassified-to-profit-or-loss-net-of-tax https://stock.noler.com/us/stock/calliditas-therapeutics-ab/operating-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-adjustments-for-noncash-items https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-comprehensive-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-current-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-current-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-current-receivables https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-expense-by-function https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-finance-cost https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-income https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-longterm-benefits https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-longterm-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-noncurrent-liabilities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-noncurrent-receivables https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-operating-income-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/other-reserves https://stock.noler.com/us/stock/calliditas-therapeutics-ab/payments-for-debt-issue-costs https://stock.noler.com/us/stock/calliditas-therapeutics-ab/payments-for-share-issue-costs https://stock.noler.com/us/stock/calliditas-therapeutics-ab/payments-from-changes-in-ownership-interests-in-subsidiaries https://stock.noler.com/us/stock/calliditas-therapeutics-ab/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/payments-to-acquire-or-redeem-entitys-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/postemployment-benefit-expense-defined-contribution-plans https://stock.noler.com/us/stock/calliditas-therapeutics-ab/prepayments-and-accrued-income-including-contract-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-contributions-of-noncontrolling-interests https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-exercise-of-warrants https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-issuing-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-sale-or-issue-of-treasury-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/proceeds-from-sales-or-maturity-of-financial-instruments-classified-as-investing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/profit-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/profit-loss-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/calliditas-therapeutics-ab/profit-loss-attributable-to-owners-of-parent https://stock.noler.com/us/stock/calliditas-therapeutics-ab/profit-loss-before-tax https://stock.noler.com/us/stock/calliditas-therapeutics-ab/profit-loss-from-operating-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/property-plant-and-equipment https://stock.noler.com/us/stock/calliditas-therapeutics-ab/purchase-of-financial-instruments-classified-as-investing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/purchase-of-intangible-assets-classified-as-investing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/purchase-of-property-plant-and-equipment-classified-as-investing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/purchase-of-treasury-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/raw-materials https://stock.noler.com/us/stock/calliditas-therapeutics-ab/raw-materials-and-consumables-used https://stock.noler.com/us/stock/calliditas-therapeutics-ab/repayments-of-borrowings-classified-as-financing-activities https://stock.noler.com/us/stock/calliditas-therapeutics-ab/research-and-development https://stock.noler.com/us/stock/calliditas-therapeutics-ab/reserve-of-exchange-differences-on-translation https://stock.noler.com/us/stock/calliditas-therapeutics-ab/retained-earnings https://stock.noler.com/us/stock/calliditas-therapeutics-ab/revenue-from-contracts-with-customers https://stock.noler.com/us/stock/calliditas-therapeutics-ab/revenue-from-interest https://stock.noler.com/us/stock/calliditas-therapeutics-ab/revenue-that-was-included-in-contract-liability-balance-at-beginning-of-period https://stock.noler.com/us/stock/calliditas-therapeutics-ab/rightofuse-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/sale-or-issue-of-treasury-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/sales-and-marketing-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/sga-expense https://stock.noler.com/us/stock/calliditas-therapeutics-ab/share-issue-related-cost https://stock.noler.com/us/stock/calliditas-therapeutics-ab/tax-effect-of-expense-not-deductible-in-determining-taxable-profit-tax-loss https://stock.noler.com/us/stock/calliditas-therapeutics-ab/tax-effect-of-foreign-tax-rates https://stock.noler.com/us/stock/calliditas-therapeutics-ab/tax-effect-of-revenues-exempt-from-taxation-2011 https://stock.noler.com/us/stock/calliditas-therapeutics-ab/tax-effect-of-tax-losses https://stock.noler.com/us/stock/calliditas-therapeutics-ab/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/calliditas-therapeutics-ab/total-assets https://stock.noler.com/us/stock/calliditas-therapeutics-ab/trade-and-other-current-payables https://stock.noler.com/us/stock/calliditas-therapeutics-ab/trade-and-other-current-receivables https://stock.noler.com/us/stock/calliditas-therapeutics-ab/transaction-price-allocated-to-remaining-performance-obligations https://stock.noler.com/us/stock/calliditas-therapeutics-ab/treasury-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/unused-provision-reversed-other-provisions https://stock.noler.com/us/stock/calliditas-therapeutics-ab/unused-tax-losses-for-which-no-deferred-tax-asset-recognised https://stock.noler.com/us/stock/calliditas-therapeutics-ab/wages-and-salaries https://stock.noler.com/us/stock/calliditas-therapeutics-ab/weighted-average-shares https://stock.noler.com/us/stock/calliditas-therapeutics-ab/work-in-progress